/TMD.TO
TMD.TO Stock - Titan Medical Inc.
Healthcare|Medical - DevicesTSX
$1.13+2150.00%
+$1.07 (+2150.00%) • Oct 15
66
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.92
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.41
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.24
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for TMD.TO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$1.11 – $1.14
TARGET (TP)$1.29
STOP LOSS$1.04
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.98
52W High$1.25
52W Low$0.04
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $17.63M | N/A | $20.09M | $20.00M | N/A |
| Gross Profit | $17.63M | N/A | $20.09M | $20.00M | N/A |
| Gross Margin | 100.0% | N/A | 100.0% | 100.0% | N/A |
| Operating Income | $4.84M | $-44,487,000 | $-30,987,000 | $2.95M | $-61,246,763 |
| Net Income | $6.95M | $-42,542,000 | $-14,858,000 | $-25,275,873 | $-42,330,068 |
| Net Margin | 39.4% | N/A | -73.9% | -126.4% | N/A |
| EPS | $0.06 | $-0.38 | $-0.14 | $-0.38 | $-1.38 |
Company Overview
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
TMD.TOBeat Rate
64%
Last 11 quarters
Avg Surprise
+43.7%
EPS vs Estimate
Beats / Misses
7/4
Last 12 quarters
Latest EPS
$-0.01
Q3 2024
EPS Surprise History
Q4 22
+18.5%
$-0.12vs$-0.15
Q1 23
No data
Q2 23
+81.0%
$-0.03vs$-0.16
Q3 23
+181.3%
$0.13vs$-0.16
Q4 23
+100.4%
$0.00vs$-0.18
Q1 24
+79.7%
$-0.04vs$-0.19
Q2 24
No data
Q3 24
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 11, 2025 | — | — | — | — |
Q2 2025 | May 12, 2025 | — | — | — | — |
Q1 2025 | Mar 27, 2025 | — | — | — | — |
Q4 2024 | Oct 31, 2024 | — | — | — | — |
Q3 2024 | Aug 15, 2024 | — | $-0.01 | — | — |
Q2 2024 | May 13, 2024 | — | $-0.01 | — | — |
Q1 2024 | Mar 29, 2024 | $-0.19 | $-0.04 | +79.7% | ✓ BEAT |
Q4 2023 | Nov 2, 2023 | $-0.18 | $0.00 | +100.4% | ✓ BEAT |
Q3 2023 | Aug 10, 2023 | $-0.16 | $0.13 | +181.3% | ✓ BEAT |
Q2 2023 | Jun 9, 2023 | $-0.16 | $-0.03 | +81.0% | ✓ BEAT |
Q1 2023 | Mar 24, 2023 | — | $-0.14 | — | — |
Q4 2022 | Nov 10, 2022 | $-0.15 | $-0.12 | +18.5% | ✓ BEAT |
Q3 2022 | Aug 11, 2022 | $-0.09 | $-0.10 | -11.1% | ✗ MISS |
Q2 2022 | May 12, 2022 | $-0.10 | $-0.08 | +20.0% | ✓ BEAT |
Q1 2022 | Mar 24, 2022 | $-0.13 | $0.08 | +161.5% | ✓ BEAT |
Q4 2021 | Nov 11, 2021 | $-0.06 | $-0.08 | -33.3% | ✗ MISS |
Q3 2021 | Aug 11, 2021 | $-0.01 | $-0.01 | -66.7% | ✗ MISS |
Q2 2021 | May 17, 2021 | $-0.10 | $-0.15 | -50.0% | ✗ MISS |
Q1 2021 | Feb 22, 2021 | — | $-0.32 | — | — |
Q4 2020 | Nov 16, 2020 | — | $-0.03 | — | — |
Latest News
Loading news...
Frequently Asked Questions about TMD.TO
What is TMD.TO's current stock price?
Titan Medical Inc. (TMD.TO) is currently trading at $1.13 per share. The stock has moved +2150.00% today.
What is the analyst price target for TMD.TO?
No analyst price targets are currently available for this stock.
What sector is Titan Medical Inc. in?
Titan Medical Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the TSX exchange.
What is TMD.TO's market cap?
Titan Medical Inc. has a market capitalization of $0.13 billion, making it a small-cap company.
Does TMD.TO pay dividends?
No, Titan Medical Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorASTI.CN
Aquarius Surgical Technologies Inc.
$0.01
Mkt Cap: $0.0B
ATE.TO
Antibe Therapeutics Inc.
$0.29
Mkt Cap: $0.0B
BHSC.CN
BioHarvest Sciences Inc.
$7.95
Mkt Cap: $0.1B
GDNS.CN
Goodness Growth Holdings, Inc.
$0.63
Mkt Cap: $0.1B
NOVC.TO
Nova Cannabis Inc.
$1.74
Mkt Cap: $0.1B
NVCN.TO
Neovasc Inc.
$40.15
Mkt Cap: $0.1B
ONC.TO
Oncolytics Biotech Inc.
$1.42
Mkt Cap: $0.1B
QIPT.V
Quipt Home Medical Corp.
$4.13
Mkt Cap: $0.2B
SBBC.V
Simply Better Brands Corp.
$0.92
Mkt Cap: $0.1B
SGMD.V
Salona Global Medical Device Corporation
$0.22
Mkt Cap: $0.0B
Explore stocks similar to TMD.TO for comparison